Direkt zum Inhalt
Merck
  • Impaired microglial activation in the brain of IL-18-gene-disrupted mice after neurovirulent influenza A virus infection.

Impaired microglial activation in the brain of IL-18-gene-disrupted mice after neurovirulent influenza A virus infection.

Virology (2001-08-16)
I Mori, M J Hossain, K Takeda, H Okamura, Y Imai, S Kohsaka, Y Kimura
ZUSAMMENFASSUNG

Knockout of the interleukin-18 (IL-18) gene predisposed mice to impaired clearance of neurovirulent influenza A virus-infected neurons from the brain. In wild-type mice, IL-18 molecule-producing microglia/macrophages emerged in virally attacked regions as early as day 3 after infection. Microglial transformation into macrophages culminated at day 7 to 9, with upregulated expression of Iba1, a novel calcium-binding protein that controls phagocytic functions of microglia/macrophages. In IL-18-/- mice, microglial transformation was interrupted with reduced Iba1 expression. Interferon-gamma (IFN-gamma)-immunopositive neurons appeared in and around virally invaded regions in wild-type mice, peaking in number at day 7, whereas such cells were barely detected in IL-18-/- mice. Stereotaxic microinjection of recombinant IFN-gamma triggered microglial transformation in IL-18-/- mice and upregulated Iba1 expression, leading to effective eradication of virally infected neurons. Collectively, these results suggest that IL-18 plays a key role in activating microglial functions directed against the influenza virus infection by inducing neuronal IFN-gamma in the brain parenchyma.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Anti-Neuronen-spezifische-Enolase-Antikörper, Klon 5E2, clone 5E2, Chemicon®, from mouse